Two Fridays ago, I spent my day developing two new webinars so my patients, present and future, will be informed and updated. While the ultimate regenerative educational experience will take place at the time of an office visit and consultation, I believe the best patients are those most informed. The webinar concerning the FDA approved Clinical Trial for creating a new drug termed Stromal Vascular Fraction out of your adipose tissue recovered during a mini-liposuction, is already accessible on my web site at sheinkopmd.com; here is a link to review my newly produced webinar for the primary joint restorative and regenerative procedures that I do: https://www.youtube.com/watch?v=rzfkdzKJ9j8&feature=youtu.be
You will note in the latter, an overview of all the procedures that I use in my practice, all are evidence-based and FDA compliant. I am one of a handful of cellular orthopedic surgeons who have substituted a needle for a knife in an attempt to assist a patient in postponing, perhaps even avoiding a major surgical procedure for an arthritic joint.
It is difficult for the reader and viewer to realize the time and effort involved in practicing evidence-based regenerative medicine; the much easier approach is an anecdote and a bill. Below I will share an edited abstract of the latest abstract that I am submitting to an Ortho Biologic meeting and shortly thereafter, to a major scientific journal for publication.
Title: Minimum 12-month Clinical Outcomes of a Combined Intraosseous and Intraarticular Treatment of Knee Osteoarthritis with Autologous BMC
ABSTRACT
Purpose: To summarize safety and outcomes in a clinical study in which study subjects with knee osteoarthritis (OA) were treated with a bone marrow concentrate (BMC) preparation who received a split treatment of autologous BMC implanted intraosseous into the tibial plateau and intraarticular.
Conclusion: Study subjects tolerated the outpatient procedure, performed with conscious sedation, reporting only mild discomfort resolving within 2-3 days post-procedure. The combined intraarticular/intraosseous BMC therapeutic approach appeared to provide moderate to significant pain relief and improvement in functional scores for 80% of the patients (KSS-Knee, LEFS and VAS). All study subjects have remained in the study as of an average of 1.5 yrs post-treatment.
To learn more visit my website at sheinkopmd.com.
To schedule an appointment for the consultation call (312) 475-1893.